Bruker (BRKR) Total Current Liabilities (2010 - 2026)
Bruker's (BRKR) quarterly Total Current Liabilities came in at $1.2 billion in Q2 2026, down 10.59% on a YoY basis from $1.3 billion in Q2 2025, and down 11.1% quarter-over-quarter from $1.4 billion in Q1 2026.
Analysis
Bruker (BRKR) Total Current Liabilities (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Total Current Liabilities for 17 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities fell 10.59% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (down 10.59% YoY), and the FY2025 full-year result was $1.3 billion, changed 0.16% from the prior year.
- Total Current Liabilities retreated to $1.2 billion in Q2 2026 per BRKR's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.4 billion in Q1 2026 and bottomed at $818.4 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2023.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities retreated 14.27% in 2022, then soared 31.48% in 2023.
- Over 5 years, Total Current Liabilities stood at $914.3 million in 2022, then jumped by 31.48% to $1.2 billion in 2023, then rose by 6.59% to $1.3 billion in 2024, then fell by 0.16% to $1.3 billion in 2025, then retreated by 5.82% to $1.2 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.2 billion, $1.4 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 2.29 Bn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 1.58 Bn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 1.28 Bn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 163.70 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 961.30 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 132.66 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 118.51 Mn |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | 1.20 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 1.35 Bn |
| Mar 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 1.28 Bn |
| Sep 30, 2024 | 1.32 Bn |
| Jun 30, 2024 | 1.30 Bn |
| Mar 31, 2024 | 1.18 Bn |
| Dec 31, 2023 | 1.20 Bn |
| Sep 30, 2023 | 1.07 Bn |
| Jun 30, 2023 | 1.05 Bn |
| Mar 31, 2023 | 1.05 Bn |
| Dec 31, 2022 | 914.30 Mn |
| Sep 30, 2022 | 864.60 Mn |
| Jun 30, 2022 | 818.40 Mn |
| Mar 31, 2022 | 880.50 Mn |
| Dec 31, 2021 | 938.50 Mn |
| Sep 30, 2021 | 921.20 Mn |